Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs

Bibliography

• GURSOY RN, BENITA S: Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drug. Biomed. Pharmacother. (2004) 58(3):173-82.
   PubMed Web of Science ®Google Scholar
• WASAN KM: Formulations and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems. Drug Devel. Ind. Pharm. (2001) 27(4):267-276.
   PubMed Web of Science ®Google Scholar
• BAGWE RP, KANICKY JR, PALLA BJ, PATANJALI PK, SHAH DO: Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit. Rev. Ther. (2001) 18(1):77-140.
   PubMed Web of Science ®Google Scholar
• HAUSE D: Lipid based systems for oral drug delivery: enhancing the bioavailability of poorly soluble drugs. Am. Pharm. Rev. (2002) Nov/Dec:22-26.
   Google Scholar
• CHARMAN CH: Lipids, lipophilic drugs and oral drug delivery - some emerging concepts. J. Pharm. Sci. (2000) 89:967-978.
   PubMed Web of Science ®Google Scholar
• POUTON CW: Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci. (2000) 11(Suppl. 2):S93-S98.
   PubMed Web of Science ®Google Scholar
• HUMBERSTONE AJ, CHARMAN WN: Lipid-based vehicles for oral delivery of poorly soluble drugs. Adv. Drug Deliv. Rev. (1997) 25:103-128.
   Web of Science ®Google Scholar
• POUTON CW: Formulations of self-emulsifying drug delivery systems. Adv. Drug Delev. Rev. (1997) 25:47-48.
   Web of Science ®Google Scholar
• VONDERSCHER J, MEINZER A: Rationale for the development of Sandimmune Neoral. Transplant. Proc. (1994) 26(5):2925-2927.
   PubMed Web of Science ®Google Scholar
• MEINZER A, MUELLER E, VONDERSCHER J: Microemulsion-A suitable galenical approach for the absorption enhancement of low soluble compounds? B.T. Gattefosse (1995) N88:21-27.
   Google Scholar
• WIGNOT TM, STEWART RP, SCHRAY KJ, DAS S, SIPOS T: In vitro studies of the effects of HAART drugs and excipients on activity of digestive enzymes. Pharm. Res. (2004) 21(3):420-427.
   PubMed Web of Science ®Google Scholar
• SHERMAN DS, FISH DN: Management of protease inhibitor associated diarrhea. Clin. Infec. Dis. (2000) 30:908-914.
   PubMed Web of Science ®Google Scholar
• POELMA FG, BREAS R, TUKKER JJ, CROMMELIN DJ: Intestinal absorption of drugs. The influence of mixed micelles on the disappearance kinetics of drugs from the small intestine of the rat. J. Pharm. Pharmacol. (1991) 43(5):317-324.
   PubMed Web of Science ®Google Scholar
• POELMA FG, BREAS R, TUKKER JJ, JOSEF J: Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat. Pharm. Res. (1990) 7(4):392-397.
   PubMed Web of Science ®Google Scholar
• CHIU YY, HIGAKI K, NEUDECK BL, BARNETT JL, WELAGE LS, AMIDON GL: Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells. Pharm. Res. (2003) 20(5):749-756.
   PubMed Web of Science ®Google Scholar
• HIGUCHI T: Physical chemical analysis of the percutaneous absorption process. J. Soc. Cosmet. Chemists. (1960) 11:85-97.
   Web of Science ®Google Scholar
• MEGRAB NA, WILLIAMS AC, BARRY BW: Oestradiol permeation through human skin silastic membrane: effects of propylene glycol and supersaturation. J. Control. Rel. (1995) 36:277-294.
   Web of Science ®Google Scholar
• MA X, TAW J, CHIANG C: Control of drug crystallization in transdermal matrix systems. Int. J. Pharm. (1996) 142:115-119.
   Web of Science ®Google Scholar
• SCHWARB FP, IMANIDIS NG, SMITH EW, HAIGH JM, SURBER C: Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm. Res. (1997) 16:909-915.
   Web of Science ®Google Scholar
• RAGHAVAN SL, TRIVIDIC A, DAVIS AF, HADGRAFT J: Crystallization of hydrocortisone acetate: influence of polymers. Int. J. Pharm. (2001) 212:213-221.
   PubMed Web of Science ®Google Scholar
• RAGHAVAN RL, KIEPFER B, DAVIS AF, KAZARIAN SG, HADGRAFT J: Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int. J. Pharm. (2001) 221:95-105.
   PubMed Web of Science ®Google Scholar
• PELLET MA, DAVIS AF, HADGRAFT J: Effect of supersaturation on membrane transport: 2. Piroxicam. Int. J. Pharm. (1994) 111:1-6.
   Web of Science ®Google Scholar
• PELLET MA, CASTELLANO S, HADGRAFT J, DAVIS AF: The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J. Control. Rel. (1997) 46:205-214.
   Web of Science ®Google Scholar
• PELLET MA, ROBERTS MS, HADGRAFT J: Supersaturated solutions evaluated with an intro stratum corneum tape stripping technique. Int. J. Pharm. (1997) 151:91-98.
   Web of Science ®Google Scholar
• RAGHAVAN RL, TRIVIDIC A, DAVIS AF, HADGRAFT J: Effects of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int. J. Pharm. (2000) 193:231-237.
   PubMed Web of Science ®Google Scholar
• IERVOLINO M, RAGHAVAN RL, HADGRAFT J: Membrane penetration enhancement of ibuprofen using supersaturation. Int. J. Pharm. (2000) 198:229-238.
   PubMed Web of Science ®Google Scholar
• IERVOLINO M, CAPPELLO B, RAGHAVAN RL, HADGRAFT J: Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int. J. Pharm. (2001) 212:131-141.
   PubMed Web of Science ®Google Scholar
• SIMONELLI AP, MEHTA SC, HIGUCHI WI: Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. J. Pharm. Sci. (1970) 59:633-638.
   PubMed Web of Science ®Google Scholar
• SEKIKAWA H, FUJIWARA J, NAGANUMA T, NAKANO M, ARITA T: Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate. Chem. Pharm. Bull. (1978) 26:3033-3039.
   PubMed Web of Science ®Google Scholar
• SUZUKI H, SUNADA H: Comparison of nicotiamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. Chem. Pharm. Bull. (1997) 45(10):1688-1693.
   PubMed Web of Science ®Google Scholar
• SUZUKI H, SUNADA H: Some factors influencing the dissolution of solid dispersions with nicotiamide and hydroxypropylmethycellulose as combined carriers. Chem. Pharm. Bull. (1998) 46(6):1015-1020.
   Web of Science ®Google Scholar
• YAMADA T, SAITO N, IMAI T, OTAGIRI M: Effect of grinding with hydroxypropyl cellulose on dissolution and particle size of a poorly water-soluble drug. Chem. Pharm. Bull. (1999) 47(9):1311-1313.
   PubMed Web of Science ®Google Scholar
• KOHRI N, YAMAYOSHI Y, XIN H et al.: Improving the oral bio-availability of albendazole in rabbits by the solid dispersion technique. J. Pharm. Pharmacol. (1999) 51:159-164.
   PubMed Web of Science ®Google Scholar
• HASEGAWA A, NAKAGAWA H, SUGIMOTO I: Application of solid dispersions of nifedipine with enteric coating agent to prepare a sustained-release dosage form. Chem. Pharm. Bull. (1985) 33(4):1615-1619.
   PubMed Web of Science ®Google Scholar
• O’DRISCOLL KM, CORRIGAN OI: Chlorothiazide-polyvinylpyrrolidone (PVP) interactions: influence on membrane permeation (everted rat intestine) and dissolution. Drug Devel. Ind. Pharm. (1982) 8(4):547-564.
   Web of Science ®Google Scholar
• USUI F, MAEDA K, KUSAI A, NISHIMURA K, YAMAMOTO K: Inhibitory effects of water soluble polymers on precipitation of RS-8359. Int. J. Pharm. (1997) 154:59-66.
   Web of Science ®Google Scholar
• HASEGAWA A, TAGUCHI M, SUZUKI R, MIYATA T, NAKAGAWA H, SUGIMOTO I: Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. Chem. Pharm. Bull. (1988), 36(12):4941-4950.
   PubMed Web of Science ®Google Scholar
• GAO P, GUYTON ME, HUANG T, BAUER JM, STEFANSKI KJ, LU Q: Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Devel. Ind. Pharm. (2004) 30(2):221-229.
   PubMed Web of Science ®Google Scholar
• GAO P, RUSH RD, PFUND WP et al.: Development of a supersaturatable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci. (2003) 92(12):2395-2407.
   Google Scholar
• LI LY, RODRIGUEZ-HORNEDO N, HEIMBACH, T, FLEISHER D: In-vitro crystallization of indinavir in the presence of ritonavir and as a function of pH. J. Pharm. Pharmacol. (2003) 55(5):707-711.
   PubMed Web of Science ®Google Scholar
• TANG L, KHAN SU, MUHAMMAD NA: Evaluation and selection of Bio-relevant dissolution media for a poorly water soluble new chemical entity. Pharm. Dev. Tech. (2002) 6(4):531-540.
   Web of Science ®Google Scholar
• LEE J, LEE SC, ACHARYA G, CHANG C, PARK K: Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property. Pharm. Res. (2003) 20(7):1022-1030.
   PubMed Web of Science ®Google Scholar
• STRAUDINGER RM: Chapter 9 Biopharmaceutics of paclitaxel (Taxol®): formulation, activity, and pharmacokinetics. In: Taxol Science and Applications. M Suffness (Ed.), CRC Press, Inc., New York, NY, USA (1995).
   Google Scholar
• In: Handbook on Injectable Drugs (8th Edition). LA Trissel (Ed.) American Society of Health-System Pharmacists, Bethedsa, MD, USA (1994):808.
   Google Scholar
• NUIJEN B, BOUMA M, SCHELLENS JH, BEIJNEN JH: Progress in the development of alternative pharmaceutical formulations of taxanes. Inv. New Drugs. (2001) 19:143-153.
   PubMed Web of Science ®Google Scholar
• ZUYLEN LV, VERWEIJ J, SPARREBOOM A: Role of formulation vehicles in taxane pharmacology. Inv. New Drugs. (2001) 19:125-141.
   PubMed Web of Science ®Google Scholar
• LASSUS M, SCOTT D, LEYLAND JB: Allergic reactions associated with Cremophor containing antineoplastics. Proc. Am. Soc. Clin. Oncol. (1985) 4:268.
   Google Scholar
• MALINGRE MM, BEIJNEN JH, SCHELLENS JH: Oral delivery of taxanes. Inv. New Drugs. (2001) 19:155-162.
   PubMed Web of Science ®Google Scholar
• BARDELEIJER HA, TELLINGEN OV, SCHELLENS JH, BEIJNEN JH: The oral route of the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery. Inv. New Drugs. (2000) 18:231-241.
   PubMed Web of Science ®Google Scholar
• TERWOGT JM, MALINGRE MM, BEIJNEN JH et al.: Coadministration of oral cyclosporin A enables oral therapy with paclitaxel. Clin. Cancer Res. (1999) 5:3379-3384.
   PubMed Web of Science ®Google Scholar
• MALINGRE MM, BEIJNEN JH, ROSING H et al.: A Phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A. Cancer Chemother. Pharmacol. (2001) 47:347-354.
   PubMed Web of Science ®Google Scholar
• WOO JS, LEE CH, SHIM CK, HWANG SJ: Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031. Pharm. Res. (2003) 20:24-30.
   PubMed Web of Science ®Google Scholar
• MONTASERI H, JAMALI F, MICETICH RG, DANESHTALAB M: Improving oral bioavailability of Taxol. Pharm. Res. (1995) 12:S-429.
   Google Scholar
• GAO P, MOROZOWICH W: Design and development of supersaturatable SEDDS (S-SEDDS) formulations for enhancing the gastrointestinal absorption of poorly soluble drugs. In: Lipid Based Drug Delivery of Poorly Water Soluble Drugs. D Hauss (Ed.), Marcel Dekker, New York, NY, USA (In press).
   Google Scholar
• DRESSMAN JB, REPPAS C: In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. (2000) 11(Suppl. 2):S73-S80.
   PubMed Web of Science ®Google Scholar
• VOGELPOEL H, WELINK J, AMIDON GL et al.: Commentary: Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J. Pharm. Sci. (2004) 93(8):1945-1956.
   PubMed Web of Science ®Google Scholar
• RAUB TJ, BARSUHN CL, WILLIAMS LR, DECKER DE, SAWADA GA, HO NF: Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. J. Drug Target. (1993) 1(4):269-286.
   PubMed Web of Science ®Google Scholar
• KOSSENA GA, CHARMAN WN, BOYD BJ, PORTER CJ: Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. J. Pharm. Sci. (2005) 94(3):481-492.
   PubMed Web of Science ®Google Scholar
• HE X, KADOMURA S, TAKEKUMA Y, SUGAWARA M, MIYAZAKI K: A new system for the prediction of drug absorption using a pH-controlled Caco-2 model: evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption. J. Pharm. Sci. (2004) 93(1):71-77.
   PubMed Web of Science ®Google Scholar
• DELANEY B, STEVENS LA, SCHMELZER W et al.: Oral absorption of phytosterols and emulsified phytosterols by Sprague-Dawley rats. J. Nutri. Biochem. (2004) 15(5):289-295.
   PubMed Web of Science ®Google Scholar
• PORTER CJ, CHARMAN WN: In vitro assessment of oral lipid based formulations. Adv. Drug Del. Rev. (2001) 50(Suppl. 1):S127-147.
   PubMed Web of Science ®Google Scholar
• OSTLUND RE Jr, MCGILL JB, ZENG C et al.: Gastrointestinal absorption and plasma kinetics of soy D5-phytosterols and phytostanols in humans. Am. J. Physiol. (2002), 282(4):E911-E916.
   PubMed Web of Science ®Google Scholar
• BÖRGSTROM B, DAHLQUIST A, LUNDH G, SJÖVALL J: Studies of intestinal digestion and absorption in the human. J. Clin. Invest. (1957) 36:1521-1529.
   PubMed Web of Science ®Google Scholar
• BORGSTRÖM B, PATTON JS: Luminal events in gastrointestinal lipid digestion. In: Handbook of Physiology Section 6. The Gastrointestinal System IV. SG Schultz (Ed.), American Physiological Society, Bethesda, MD, USA (1991):475-504.
   Google Scholar
• STAGGERS JE, HERNELL O, STAFFORD RJ, CAREY MC: Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry (1990) 29:2028-2040.
   PubMed Web of Science ®Google Scholar
• HERNELL O, STAGGERS JE, CAREY MC: Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochem. (1990) 29:2041-2056.
   PubMed Web of Science ®Google Scholar
• CAREY MC, SMALL DM: The characteristics of mixed micellar solutions with particular reference to bile. Am. J. Med. (1970) 49:590-598.
   PubMed Web of Science ®Google Scholar
• HOFMANN AF, BORGSTRÖM B: The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J. Clin. Invest. (1964) 43:247-257.
   PubMed Web of Science ®Google Scholar
• MATTSON FH, VOLPENHEIN RA: The digestion and absorption of triglycerides. J. Biol. Chem. (1964) 239:2772-2777.
   PubMed Web of Science ®Google Scholar
• SIMMONDS WJ, HOFMANN AF, THEODOR E: Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man. J. Clin. Invest. (1967) 45:874-890.
   Google Scholar
• WILSON FA, DIETSCHY JM: Characterization of bile acid absorption across the unstirred water layer and brush border of the rat jejunum. J. Clin. Invest. (1972) 51(12):3015-3025.
   PubMed Web of Science ®Google Scholar
• MATTSON FH, NOLEN GA: Absorbability by rats of compounds containing one to eight ester groups. J. Nutr. (1972) 102:1171-1176.
   PubMed Web of Science ®Google Scholar
• GROVES MJ, MUSTAFA RM: Measurement of the ‘spontaneity’ of self-emulsifiable oils. J. Phar. Pharmacol. (1974) 26:671-681.
   Web of Science ®Google Scholar
• MANSBACH CM, COHEN RS, LEFF PB: Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man. J. Clin. Invest. (1975) 56:781-791.
   PubMed Web of Science ®Google Scholar
• WESTERGAARD H, DIETSCHY JM: The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J. Clin. Invest. (1976) 58:97-108.
   PubMed Web of Science ®Google Scholar
• HO NFH, PARK JY, MOROZOWICH W, HIGUCHI WI: Physical model approach to the design of drugs with improved intestinal absorption. In: Design of Biopharmaceutical Properties Through Prodrugs and Analogs. EB Roche (Ed.) APhA Academy of Pharmaceutical Sciences, Washington, DC, USA (1978):136-227.
   Google Scholar
• MONTET C, REYNIER MO, MONTET AM, GEROLAMI A: Distinct effects of three bile salts on cholesterol solubilization by oleate-monoolein-bile salt micelles. Biochim. Biophys. Acta. (1979) 575(2):289-294.
   PubMed Web of Science ®Google Scholar
• SHIAU YF, LEVINE GM: pH dependence of micellar diffusion and dissociation. Am. J. Physiol. (1980) 239:G177-G182.
   PubMed Web of Science ®Google Scholar
• SAWADA GA, BARSUHN CL, LUTZKE BS et al.: Increased lipophilicity and subsequent cell partitioning decrease passive transcellular diffusion of novel, highly lipophilic antioxidants. J. Pharmacol. Exp. Therap. (1999) 288(3):1317-1326.
   PubMed Web of Science ®Google Scholar
• THOMSON AB, O’BRIEN BD: Uptake of cholesterol into rabbit jejunum using three in vitro techniques: importance of bile acid micelles and unstirred layer resistance. Am. J. Physiol. (1981) 241:G270-G274.
   PubMed Web of Science ®Google Scholar
• IRANLOYE TA, PILPEL N, GROVES MJ: Some factors affecting the droplet size and charge of dilute oil-in-water emulsions prepared by self-emulsification. J. Disp. Sci. & Tech. (1983) 4(2):109-121.
   Web of Science ®Google Scholar
• SHIAU YF: Lipid digestion and absorption. In: Physiology of the Gastrointestinal Tract (2nd Ed.). LR Johnson (Ed.), Raven Press, New York, NY, USA (1987):1527-1556.
   Google Scholar
• REYNIER MO, CROTTE C, MONTET JC, SAUVE P, GEROLAMI A: Intestinal cholesterol and oleic acid uptake from solutions supersaturated with lipids. Lipids. (1987) 22(1):28-32.
   PubMed Web of Science ®Google Scholar
• POELMA FG, TUKKER JJ, CROMMELIN DJ: Intestinal absorption of drugs. I. The influence of taurocholate on the absorption of dantrolene in the small intestine of the rat. J. Pharm. Sci. (1989) 78:285-289.
   PubMed Web of Science ®Google Scholar
• THURNHOFER H, HAUSER H: Uptake of cholesterol by small intestinal brush border membrane is protein-mediated. Biochem. (1990) 29:2142-2148.
   PubMed Web of Science ®Google Scholar
• POELMA FG, BREAS R, TUKKER JJ, CROMMELIN DJ: Intestinal absorption of drugs. The influence of mixed micelles on on the disappearance kinetics of drugs from the small intestine of the rat. J. Pharm. Pharmacol. (1991) 43(5):317-324.
   PubMed Web of Science ®Google Scholar
• SMALL DM: The effects of glyceride structure on absorption and metabolism. Ann. Rev. Nutr. (1991) 11:413-434.
   PubMed Web of Science ®Google Scholar
• THURNHOFER H, SCHNABEL J, BETZ M, LIPKA G, PIDGEON C, HAUSER H: Cholesterol-transfer protein located in the intestinal brush border membrane. Partial purification and characterization. Biochim. Biophys. Acta. (1991) 1064:275-286.
   PubMed Web of Science ®Google Scholar
• LIPKA G, IMFELD D, SCHULTHESS G, THURNHOFER H, HAUSER H: Protein mediated cholesterol absorption by small intestinal brush border membranes. In: Structural and Dynamic Properties of Lipids and Membranes PG Quinn, RJ Cherry (Eds), Portland Press, London, UK (1992):7-18.
   Google Scholar
• THOMSON AB, SCHOELLER C, KEELAN M, SMITH L, CLANDININ MT: Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Can. J. Physiol. Pharm. (1993) 71:531-555.
   PubMed Web of Science ®Google Scholar
• TSO P: Intestinal lipid absorption. In: Physiology of the Gastrointestinal Tract (3rd Edition), LR Johnson (Ed.), Raven Press, New York, NY, USA (1994):1867-1907.
   Google Scholar
• SCHOELLER SC, KEELAN M, MULVEY G, STREMMEL W THOMSON AB: Oleic acid uptake into rat and rabbit jejunal brush border membranes. Biochim. Biophys. Acta. (1995) 1236:51-64.
   PubMed Web of Science ®Google Scholar
• NARAYANAN VS, STORCH J: Fatty acid transfer in taurodeoxycholate mixed micelles. Biochem. (1996) 35:7466-7473.
   PubMedGoogle Scholar
• DAWSON A, RUDEL LL: Intestinal cholesterol absorption. Curr. Opin. Lipidol. (1999) 10:315-320.
   PubMed Web of Science ®Google Scholar
• BOSNER SM, LANGE LG, STENSON WF, OSTLUND RE: Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J. Lipid. Res. (1999) 40:302-308.
   PubMed Web of Science ®Google Scholar
• WANG DQ: New concepts of mechanism of intestinal cholesterol absorption. Ann. Hepatol. (2003) 2(3):113-121.
   PubMedGoogle Scholar
• KRAMER W, GIRBIG F, CORSIERO D et al.: Intestinal cholesterol absorption: identification of different binding proteins for cholesterol and cholesterol absorption inhibitors in the enterocyte brush border membrane. Biochim. Biophys. Acta. (2003) 1633(1):13-26.
   PubMed Web of Science ®Google Scholar
• DELANEY B, STEVENS LA, SCHMELZER W et al.: Oral absorption of phytosterols and emulsified phytosterols by Sprague-Dawley rats. J. Nutr. Biochem. (2004) 15(5):289-295.
   Google Scholar
• WIEDMANN TS, LIANG W, KAMEL L: Solubilization of drugs by physiological mixtures of bile salts. Pharm. Res. (2002) 19(8):1203-1208.
   PubMed Web of Science ®Google Scholar
• CHIJIIWA K, LINSCHEER WG: Effect of intraluminal pH on cholesterol and oleic acid absorption from micellar solutions in the rat. Am. J. Physio. (1984) 246(5):G492-G499.
   PubMed Web of Science ®Google Scholar
• CHIJIIWA K, LINSCHEER WG: Mechanism of pH effect on oleic acid and cholesterol absorption in the rat. Am. J. Physio. (1987) 252(4):G506-G510.
   Google Scholar
• MISHKIN S, YALOVSKY M, KESSLER JI: Stages of uptake and incorporation of micellar palmitic acid by hamster proximal intestinal mucosa. J. Lipid Res. (1972) 13(2):155-68.
   PubMed Web of Science ®Google Scholar
• HORIUCHI K, NAITO I, NAKANO K et al.: Three-dimensional ultrastructure of the brush border glycocalyx in the mouse small intestine: a high resolution scanning electron microscopic study. Arch. Histol. Cytol. (2005) 68(1):51-6.
   PubMed Web of Science ®Google Scholar
• BAKATSELOU V, OPPENHEIM RC, DRESSMAN JB: Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm. Res. (1991) 8(12):1461-1469.
   PubMed Web of Science ®Google Scholar
• TENHOOR CN, BAKATSELOU V, DRESSMAN JB: Solubility of mefenamic acid under simulated fed- and fasted-state conditions. Pharm. Res. (1991) 8(9):1203-1205.
   PubMed Web of Science ®Google Scholar
• MITHANI SD, BAKATSELOU V, TENHOOR CN, DRESSMAN JB: Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm. Res. (1996) 13(1):163-167.
   PubMed Web of Science ®Google Scholar
• STORCH J, KLEINFELD AM: Transfer of long chain fluorescent free fatty acids between unilamellar vesicles. Biochem. (1986) 25(7):1717-1726.
   PubMed Web of Science ®Google Scholar
• CHO MJ, CHEN FJ, HUCZEK DL: Effects of inclusion complexation on the transepithelial transport of a lipophilic substance in vitro. Pharm. Res. (1995) 12(4):560-564.
   PubMed Web of Science ®Google Scholar
• HO SY, STORCH J: Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells. Am. J. Physiol. (2001) 281(4):C1106-C1117.
   PubMed Web of Science ®Google Scholar
• SCHULTHESS G, LIPKA G, COMPASSI S et al.: Absorption of monoacylglycerols by small intestinal brush border membrane. Biochem. (1994) 33(15):4500-4508.
   PubMed Web of Science ®Google Scholar
• HSU KT, STORCH J: Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms. J. Biol. Chem. (1996) 271(23):13317-13323.
   PubMed Web of Science ®Google Scholar
• TROTTER PJ, HO SY, STORCH J: Fatty acid uptake by Caco-2 human intestinal cells. J. Lipid Res. (1996) 37(2):336-346.
   PubMed Web of Science ®Google Scholar
• HO SY, DELGADO L, STORCH J: Monoacylglycerol metabolism in human intestinal Caco-2 cells: evidence for metabolic compartmentation and hydrolysis. J. Biol. Chem. (2002) 277(3):1816-1823.
   PubMed Web of Science ®Google Scholar
• CONSTANTINIDES PP, SCALART JP: Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides. Int. J. Pharm. (1997) 158:57-68.
   Web of Science ®Google Scholar
• HAUSS DJ, FOGAL SE, FICORILLI JV et al.: Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. (1998) 87:164-169.
   PubMed Web of Science ®Google Scholar
• HAQUE A, MORRIS ER: Thermogelation of methylcellulose. Part I. Molecular structures and processes. Carbohydrate Polymers (1993) 22:161-173.
   Web of Science ®Google Scholar
• HAQUE A, RICHARDSON RK, MORRIS ER, GIDLEY MJ, CASWELL DC: Thermogelation of methylcellulose. Part II. Effect of hydroxypropyl substituents. Carbohydrate Polymers (1993) 22:175-186.
   Web of Science ®Google Scholar
• ZILLER KH, RUPPRECHT H: Control of crystal growth in drug suspensions. Drug Dev. Ind. Pharm. (1988) 14:2341-2370.
   Web of Science ®Google Scholar